BEN domain-containing protein 7 (BEND7)

BEN domain-containing protein 7 (BEND7) is a protein encoded by the BEND7 gene in humans and belongs to the family of BEN domain-containing proteins[1][3][4][5]. The BEN domain is a recognized DNA-binding domain found in various animal proteins involved in transcriptional regulation and chromatin remodeling[2]. BEND7 is predicted to mediate DNA binding and localizes to the extracellular exosome, but its precise biological functions, DNA sequence specificity, and roles in physiology remain undefined[1][3][4][5][6][8]. Disease associations in genetic databases include hypertension and brachydactyly syndrome and immunodeficiency-centromeric instability-facial anomalies syndrome, but direct functional data or implications for BEND7 as a therapeutic target are currently lacking[3]. No drugs are known to target BEND7, and there are no specific safety concerns or biomarker information available[3][4][5]. **Important context:** - There are *no functional studies reported on BEND7* specifically; functional inference is largely based on analogy with other BEN domain-containing proteins[2]. - BEND7 is not considered a therapeutic target at this time, and there is no evidence it acts as a receptor, enzyme, transporter, or other druggable class[1][3][5]. - Most information is predicted or by homology, not experimentally validated for this specific protein[2][3]. **Summary:** BEND7 is a BEN domain-containing, DNA-binding protein with predicted nuclear/chromatin functions, but its *biological role and therapeutic relevance remain unknown* and unstudied.

Other names

BEN domain containing 7C10orf30FLJ40283BEN domain-containing protein 7